Replies to post #10964 on GTC Biotherapeutics (fka GTCB)

[DragonBits]

GTC can't afford any more partnerships that are structured like the LEO and LFB deals, it is those deals that are causing them to spend so much money and to keep doing these placements. And GTC has too keep up with the spending or lose out big time in the future.

Makes for an interesting situation, at some point the stock will be a huge winner, but for current shareholders the company is a black hole sucking up cash.

[Caiostro]

I think Cox mentioned end of June in the hope that on rumours the stock maybe will climb to above $1 for 10 days.

Forget the partner in June.

And keep the latest dilution at 0,87 in mind.

Things are only getting more worse for the shareholders because of the financial problems and a much too high cashburn.

When Cox retires he'll count his money he got from you and me and will laugh very loud.....